Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.
about
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedureImplementation of a nurse-delivered intravitreal injection service.A safety audit of the first 10 000 intravitreal ranibizumab injections performed by nurse practitionersEffects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injectionsAdjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.Endophthalmitis: state of the art.Comparison of two anesthetic methods for intravitreal ozurdex injectionSevere Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.Survey of intravitreal injection techniques among retina specialists in Israel.Fungal endophthalmitis associated with compounded productsBurkholderia cepacia endophthalmitis, in a penicillin allergic patient, following a ranibizumab injection.Transformational change: nurses substituting for ophthalmologists for intravitreal injections - a quality-improvement report.Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.Prevention and treatment of injection-related endophthalmitis.Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications.Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis.Bacterial and Fungal Endophthalmitis.The effect of posterior sub-Tenon's capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema.Clinical outcomes and antibiotic susceptibilities of Staphylococcus aureus endophthalmitis.A survey of UK practice patterns in the delivery of intravitreal injections.Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.The role of antibiotics in the prevention of post-intravitreal anti-VEGF endophthalmitis: primum non nocere!The short-needle intravitreal injection technique.Subconjunctival anaesthesia for intravitreal injections.Reply to Alexander et al (Subconjunctival anaesthesia for intravitreal injections).Reply to Bhavsar et al.Intravitreal injections, antibiotics and endophthalmitis.Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.Vitreous hemorrhage as an early sign of acute bacterial endophthalmitis following intravitreal ranibizumab injection.Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.Prospective comparison of low-fluence photodynamic therapy combined with intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration.
P2860
Q24186065-2E09650A-859A-45D5-A3A2-EAF100544A21Q33759198-BC5DFB9E-3499-4E03-84C8-BF4BB21421CFQ34325559-2A75FD8A-001E-45A2-949C-D7BBDF123B7DQ34390583-F1823CD3-5A52-45CA-8DD9-7A8DC2CB0615Q34551772-1AC914CE-6D3C-4DA6-9F85-A6CC15CC10AEQ34952098-128750B6-69A2-4E61-9193-E62C60E1B86EQ35531482-43013481-6A7D-41F8-A914-DAE85CCF507DQ36762577-C5DBAE0C-FEED-4D60-B3CD-C84364AED391Q37021285-497E9118-9CA8-4650-9203-C3080840B0CFQ37513509-BFE346B7-90C0-4E73-B9DB-97417F8CC66CQ37588517-DBA39D83-2CFA-4D8C-8304-9D0810594E44Q37721864-642CF1DE-3E75-454A-BD15-78DEF3FCEE02Q38104396-B83D11A9-6FD9-4061-9BF3-F8E36457B1FEQ38210130-592CB8BB-3F5B-4CEA-8647-705F8AD21E07Q38261103-380E26EF-613A-40DC-8CA2-21F8AF968D76Q38758366-CD18EF2E-B220-43B0-89A2-054A1BF48863Q39207363-06E1F45E-92C5-44BB-A3B3-D7FD724DAB7EQ39248367-50D9092A-392B-4110-B839-1168CEE1C45EQ40498976-F0FB5AFB-CD5C-49A0-BD97-AFBB1CAFC5FCQ40816009-EE94561A-077C-4726-A175-6375C9C1039AQ41973171-691560CC-8235-4BC5-BA9D-F52CBD4E4EA7Q42358995-1C593598-B936-4273-A1D5-5449246A108FQ42578478-377FC5ED-6045-4316-AF79-512622711841Q42611903-3AE7031D-6C47-4DE5-8083-4289968A1E00Q42611917-67AC598D-2870-440B-B870-5C0B6403B420Q42781980-961525D3-3C5C-4862-983C-DC6CCBE1229FQ42782011-29BB9E6A-6185-47A3-9033-337131FDA9C8Q47406772-880A3718-DB6A-4800-ADDE-790F4A1D1394Q48339204-2212FAE4-A6D4-4BD7-9044-783956CAB717Q50564863-E04FC2B6-B1B0-4693-9D03-F2C431890EC6Q54778471-86ED56C3-AC9B-43A6-B50F-529324816C49
P2860
Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@ast
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@en
type
label
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@ast
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@en
prefLabel
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@ast
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@en
P2093
P2860
P356
P1433
P1476
Post-intravitreal anti-VEGF en ...... s, risk factors, and outcomes.
@en
P2093
C J MacEwen
C Robertson
D A M Lyall
S T D Roxburgh
P2860
P2888
P304
P356
10.1038/EYE.2012.199
P577
2012-10-12T00:00:00Z